Central Nervous System Drugs Global Market Report 2022 – By Type (Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $4000.00 | Pages : 300 | Published : January 2022 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

The central nervous system (CNS) drugs market consists of sales of central nervous system drugs and related services by entities (organizations, sole traders and partnerships) that manufacture central nervous system drugs that are used in the treatment of diseases affecting the brain or spinal cord. The central nervous system integrates sensory information and instructs the body to respond accordingly. The spinal cord is a channel for signals between the brain and the rest of the body. CNS disorder is a condition in which the brain and spinal cord’s ability to function is affected, hence affecting the body. The market for CNS disorder drugs comprises of drugs that work in different ways depending on the type of disease by suppressing or boosting the brain activities

The main types of central nervous system (CNS) drugs are analgesics, anti-parkinson drugs, anesthetics, anti-epileptics and other CNS drugs. Analgesics, also known as painkillers, are medications that alleviate various types of pain, ranging from headaches to injuries to arthritis. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores and others.

The global central nervous system drugs market size is expected to grow from $169.11 billion in 2021 to $178.70 billion in 2022 at a compound annual growth rate (CAGR) of 5.7%. The growth in the CNS drugs market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The central nervous system drugs market is expected to reach $264.97 billion in 2026 at a CAGR of 10.3%.

The central nervous system drugs market will be driven by rapid growth in emerging markets in the forecast period. Emerging markets growth is aided by rising disposable income, stable political environment and increasing foreign investments in these countries. For instance, according to the IMF, China’s GDP growth rate was 2.3% in 2020., according to the World Economic Outlook Reports by the IMF, the global growth is 6% in 2021 and expected to be 4.4% in 2022. Thus, strong economic growth will boost the demand for central nervous system drugs and this will drive the market during the forecast period.

During the forecast period, the growth of the central nervous system drugs market will be restrained by patent expiration of branded central nervous system drugs. In general, pharmaceutical companies invest a large sum of money in the drug development process and patents. During the patency period, the company holding the patent holds exclusivity for the manufacturing and distribution of drugs. Post expiration of patency, generic versions of the drugs are manufactured by other companies with prices much lower than the original branded drugs. Overall, this will negatively impact the growth of the market in terms of value.

Many central nervous system drug manufacturers are collaborating with other manufacturers in the industry to share technical knowledge and improve product quality. These agreements are helping anti-epileptics drugs manufacturers broaden their products and services. For instance, in March 2021, SEQENS and Rondol Group had announced a collaboration in formulation research and continuous flow manufacturing for existing, repurposed, or new drugs for oncology, infectious diseases, and central nervous system disorders. In June 2021, DSM and Brains Bioceutical have established a global exclusive partnership to unlock the therapeutic potential of cannabinoids in early-stage drug development. The cannabinoid API market is rapidly expanding, fueled by strong scientific evidence demonstrating cannabinoid's potential in a variety of therapeutic areas, including Central Nervous System (CNS) diseases.

Major companies in the central nervous system drugs market include Biogen Inc, Johnson & Johnson, Novartis AG, UCB S.A., Takeda Pharmaceuticals, AbbVie, Teva Pharmaceuticals, GlaxosmithKline, Daiichi Sankyo Company and H Lundbeck.

North America was the largest region in the central nervous system drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the CNS drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the central nervous system drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam.

The global central nervous system drugs market is segmented -

1) By Type: Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Other CNS Drugs

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

    Table Of Contents

    1. Central Nervous System Drugs Market Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6. Introduction

    6.1. Segmentation By Geography

    6.2. Segmentation By Type

    6.3. Segmentation By Distribution Channel

    6.4. Segmentation By Route Of Administration

    6.5. Segmentation By Drug Classification

    6.6. Segmentation By Mode Of Purchase

    7. Central Nervous System Drugs Market Characteristics

    7.1. Market Definition

    7.2. Market Segmentation By Type

    7.2.1. Multiple Sclerosis (MS)

    7.2.2. Anti-Psychotic

    7.2.3. Analgesics

    7.2.4. Anti-Parkinson Drugs

    7.2.5. Anesthetics

    7.2.6. Anti-Epileptics

    7.2.7. Anti-Depressants

    7.2.8. Other CNS Drugs

    7.3. Market Segmentation By Distribution Channel

    7.3.1. Hospitals Pharmacies

    7.3.2. Retail Pharmacies/ Drug Stores

    7.3.3. Others

    7.4. Market Segmentation By Route Of Administration

    7.4.1. Oral

    7.4.2. Intravenous

    7.4.3. Intranasal/ Inhalation

    7.4.4. Others

    7.5. Market Segmentation By Drug Classification

    7.5.1. Branded Drugs

    7.5.2. Generic Drugs

    7.6. Market Segmentation By Mode Of Purchase

    7.6.1. Over-The-Counter Drugs

    7.6.2. Prescription-Based Drugs

    8. Central Nervous System Drugs Market, Supply Chain Analysis

    8.1. Supply Chain

    8.1.1. Raw Material Suppliers

    8.1.2. Contract Research Organization (CRO)

    8.1.3. Central Nervous System Drugs Manufacturer

    8.1.4. Contract Manufacturing Organization (CMO)

    8.2. Distribution

    8.2.1. Wholesalers/Distributors

    8.2.2. Retailers (Pharmacies) And Hospitals

    8.2.3. Neurologists

    8.3. End-Users

    9. Central Nervous System Drugs Market, Product Analysis – Product Examples

    10. Central Nervous System Drugs Market Customer Information

    10.1. Usage of Central Nervous System Medicines In Old Age Homes

    10.2. Study On Effectiveness Of Anti-Depressants

    10.3. Lower Approval Rates For Central Nervous System Drugs

    11. Central Nervous System Drugs Market Trends And Strategies

    11.1. Wearables To Improve R&D

    11.2. Biomarkers In CNS Drug Development

    11.3. Modification Of Existing Epilepsy Drugs

    11.4. Collaborations For CNS Drug Development

    11.5. Drug Pipeline

    11.6. 3D Printing Technology

    12. Leading Central Nervous System Drugs

    13. Pipeline Drugs

    14. Impact Of COVID-19 On The Central Nervous System Drugs Market

    14.1. Clinical Trial Delays

    14.2. Supply Chain Issues

    14.3. Increasing Demand For Anti-Depressants Due To COVID-19

    14.4. Future Outlook

    15. Global Central Nervous System Drugs Market Size And Growth

    15.1. Market Size

    15.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

    15.2.1. Drivers Of The Market 2015 – 2020

    15.2.2. Restraints On The Market 2015 – 2020

    15.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    15.3.1. Drivers Of The Market 2020 – 2025

    15.3.2. Restraints On The Market 2020 – 2025

    16. Central Nervous System Drugs Market, Regional Analysis

    16.1. Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.2. Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Region

    16.3. Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region

    17. Global Central Nervous System Drugs Market Segmentation

    17.1. Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.1.1. Multiple Sclerosis

    17.1.2. Other CNS drugs

    17.1.3. Anti-Psychotic

    17.1.4. Anti-Epileptics

    17.1.5. Antidepressants

    17.1.6. Anesthetics

    17.1.7. Analgesics

    17.1.8. Anti-Parkinson drugs

    17.2. Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.2.1. Hospital Pharmacies

    17.2.2. Retail Pharmacies/ Drug Stores

    17.2.3. Other Distribution Channel

    17.3. Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.3.1. Oral

    17.3.2. Intravenous

    17.3.3. Intranasal

    17.3.4. Others

    17.4. Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.4.1. Branded Drugs

    17.4.2. Generic Drugs

    17.5. Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.5.1. Prescription-Based Drugs

    17.5.2. Over-The-Counter Drugs

    18. Global Central Nervous System Drugs Market Metrics

    18.1. Central Nervous System Drugs Market Size, Percentage Of GDP, Global

    18.2. Per Capita Average Central Nervous System Drugs Market Expenditure, Global

    19. Asia-Pacific Central Nervous System Drugs Market

    19.1. Asia-Pacific Central Nervous System Drugs Market Overview

    19.1.1. Region Information

    19.1.2. Market Information

    19.1.3. COVID-19 Impact

    19.1.4. Background Information

    19.1.5. Government Initiatives

    19.1.6. Regulations

    19.1.7. Regulatory Bodies

    19.1.8. Major Associations

    19.1.9. Taxes Levied

    19.1.10. Corporate Tax Structure

    19.1.11. Investments

    19.1.12. Major Companies

    19.2. Asia-Pacific Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.3. Asia-Pacific Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.4. Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.5. Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

    19.6. Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

    19.7. Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

    19.8. Asia-Pacific Central Nervous System Drugs Market Metrics

    19.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Asia-Pacific Major Countries

    19.9. Asia-Pacific Central Nervous System Drugs Market: Country Analysis

    19.10. Australia Central Nervous System Drugs Market

    19.11. Australia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.12. Australia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.13. Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.14. China Central Nervous System Drugs Market

    19.15. China Central Nervous System Drugs Market Overview

    19.15.1. Country Information

    19.15.2. Market Information

    19.15.3. COVID-19 Impact

    19.15.4. Background Information

    19.15.5. Government Initiatives

    19.15.6. Regulations

    19.15.7. Regulatory Bodies

    19.15.8. Major Associations

    19.15.9. Taxes Levied

    19.15.10. Corporate Tax Structure

    19.15.11. Investments

    19.15.12. Major Companies

    19.16. China Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.17. China Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.18. China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.19. Hong Kong Central Nervous System Drugs Market

    19.20. Hong Kong Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.21. Hong Kong Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.22. India Central Nervous System Drugs Market

    19.23. India Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.24. India Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.25. India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.26. Indonesia Central Nervous System Drugs Market

    19.27. Indonesia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.28. Indonesia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.29. Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.30. Japan Central Nervous System Drugs Market

    19.31. Japan Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.32. Japan Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.33. Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.34. Malaysia Central Nervous System Drugs Market

    19.35. Malaysia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.36. Malaysia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.37. New Zealand Central Nervous System Drugs Market

    19.38. New Zealand Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.39. New Zealand Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.40. Philippines Central Nervous System Drugs Market

    19.41. Philippines Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.42. Philippines Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.43. Singapore Central Nervous System Drugs Market

    19.44. Singapore Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.45. Singapore Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.46. South Korea Central Nervous System Drugs Market

    19.47. South Korea Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.48. South Korea Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.49. South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.50. Thailand Central Nervous System Drugs Market

    19.51. Thailand Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.52. Thailand Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.53. Vietnam Central Nervous System Drugs Market

    19.54. Vietnam Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.55. Vietnam Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20. Western Europe Central Nervous System Drugs Market

    20.1. Western Europe Central Nervous System Drugs Market Overview

    20.1.1. Region Information

    20.1.2. Market Information

    20.1.3. COVID Impact

    20.1.4. Background Information

    20.1.5. Government Initiatives

    20.1.6. Regulations

    20.1.7. Regulatory Bodies

    20.1.8. Major Associations

    20.1.9. Taxes Levied

    20.1.10. Corporate Tax Structure

    20.1.11. Investments

    20.1.12. Major Companies

    20.2. Western Europe Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.3. Western Europe Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.4. Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    20.5. Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

    20.6. Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

    20.7. Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

    20.8. Western Europe Central Nervous System Drugs Market Metrics

    20.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Western Europe Major Countries

    20.9. Western Europe Central Nervous System Drugs Market: Country Analysis

    20.10. Austria Central Nervous System Drugs Market

    20.11. Austria Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.12. Austria Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.13. Belgium Central Nervous System Drugs Market

    20.14. Belgium Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.15. Belgium Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.16. Denmark Central Nervous System Drugs Market

    20.17. Denmark Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.18. Denmark Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.19. Finland Central Nervous System Drugs Market

    20.20. Finland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.21. Finland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.22. France Central Nervous System Drugs Market

    20.23. France Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.24. France Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.25. France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    20.26. Germany Central Nervous System Drugs Market

    20.27. Germany Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.28. Germany Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.29. Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    20.30. Ireland Central Nervous System Drugs Market

    20.31. Ireland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.32. Ireland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.33. Italy Central Nervous System Drugs Market

    20.34. Italy Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.35. Italy Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.36. Netherlands Central Nervous System Drugs Market

    20.37. Netherlands Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.38. Netherlands Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.39. Norway Central Nervous System Drugs Market

    20.40. Norway Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.41. Norway Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.42. Portugal Central Nervous System Drugs Market

    20.43. Portugal Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.44. Portugal Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.45. Spain Central Nervous System Drugs Market

    20.46. Spain Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.47. Spain Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.48. Sweden Central Nervous System Drugs Market

    20.49. Sweden Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.50. Sweden Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.51. Switzerland Central Nervous System Drugs Market

    20.52. Switzerland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.53. Switzerland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.54. UK Central Nervous System Drugs Market

    20.55. UK Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    20.56. UK Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    20.57. UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    21. Eastern Europe Central Nervous System Drugs Market

    21.1. Eastern Europe Central Nervous System Drugs Market Overview

    21.1.1. Region Information

    21.1.2. Market Information

    21.1.3. COVID Impact

    21.1.4. Background Information

    21.1.5. Government Initiatives

    21.1.6. Regulations

    21.1.7. Regulatory Bodies

    21.1.8. Major Associations

    21.1.9. Taxes Levied

    21.1.10. Corporate Tax Structure

    21.1.11. Investments

    21.1.12. Major Companies

    21.2. Eastern Europe Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    21.3. Eastern Europe Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    21.4. Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    21.5. Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

    21.6. Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

    21.7. Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

    21.8. Eastern Europe Central Nervous System Drugs Market Metrics

    21.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Eastern Europe Major Countries

    21.9. Eastern Europe Central Nervous System Drugs Market: Country Analysis

    21.10. Czech Republic Central Nervous System Drugs Market

    21.11. Czech Republic Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    21.12. Czech Republic Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    21.13. Poland Central Nervous System Drugs Market

    21.14. Poland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    21.15. Poland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    21.16. Romania Central Nervous System Drugs Market

    21.17. Romania Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    21.18. Romania Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    21.19. Russia Central Nervous System Drugs Market

    21.20. Russia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    21.21. Russia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    21.22. Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    22. North America Central Nervous System Drugs Market

    22.1. North America Central Nervous System Drugs Market Overview

    22.1.1. Region Information

    22.1.2. Market Information

    22.1.3. COVID-19 Impact

    22.1.4. Background Information

    22.1.5. Government Initiatives

    22.1.6. Regulations

    22.1.7. Regulatory Bodies

    22.1.8. Investments

    22.1.9. Major Associations

    22.1.10. Tax Levied

    22.1.11. Corporate Tax Structure

    22.1.12. Major Companies

    22.2. North America Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    22.3. North America Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    22.4. North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    22.5. North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

    22.6. North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

    22.7. North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

    22.8. North America Central Nervous System Drugs Market Metrics

    22.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, North America Major Countries

    22.9. North America Central Nervous System Drugs Market: Country Analysis

    22.10. Canada Central Nervous System Drugs Market

    22.11. Canada Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    22.12. Canada Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    22.13. Mexico Central Nervous System Drugs Market

    22.14. Mexico Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    22.15. Mexico Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    22.16. USA Central Nervous System Drugs Market

    22.17. USA Central Nervous System Drugs Market Overview

    22.17.1. Country Information

    22.17.2. Market Information

    22.17.3. COVID-19 Impact

    22.17.4. Background Information

    22.17.5. Government Initiatives

    22.17.6. Regulations

    22.17.7. Regulatory Bodies

    22.17.8. Investments

    22.17.9. Major Associations

    22.17.10. Corporate Tax Structure

    22.17.11. Major Companies

    22.18. USA Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    22.19. USA Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    22.20. USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    23. South America Central Nervous System Drugs Market

    23.1. South America Central Nervous System Drugs Market Overview

    23.1.1. Region Information

    23.1.2. Market Information

    23.1.3. COVID-19 Impact

    23.1.4. Background Information

    23.1.5. Regulations

    23.1.6. Regulatory Bodies

    23.1.7. Investments

    23.1.8. Major Associations

    23.1.9. Tax Levied

    23.1.10. Corporate Tax Structure

    23.1.11. Major Companies

    23.2. South America Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    23.3. South America Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    23.4. South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    23.5. South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

    23.6. South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

    23.7. South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

    23.8. South America Central Nervous System Drugs Market Metrics

    23.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, South America Major Countries

    23.9. South America Central Nervous System Drugs Market: Country Analysis

    23.10. Argentina Central Nervous System Drugs Market

    23.11. Argentina Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    23.12. Argentina Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    23.13. Brazil Central Nervous System Drugs Market

    23.14. Brazil Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    23.15. Brazil Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    23.16. Brazil Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    23.17. Chile Central Nervous System Drugs Market

    23.18. Chile Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    23.19. Chile Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    23.20. Colombia Central Nervous System Drugs Market

    23.21. Colombia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    23.22. Colombia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    23.23. Peru Central Nervous System Drugs Market

    23.24. Peru Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    23.25. Peru Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    23.26. Venezuela Central Nervous System Drugs Market

    23.27. Venezuela Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    23.28. Venezuela Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    24. Middle East Central Nervous System Drugs Market

    24.1. Middle East Central Nervous System Drugs Market Overview

    24.1.1. Region Information

    24.1.2. Market Information

    24.1.3. COVID-19 Impact

    24.1.4. Background Information

    24.1.5. Government Initiatives

    24.1.6. Regulations

    24.1.7. Regulatory Bodies

    24.1.8. Major Associations

    24.1.9. Taxes Levied

    24.1.10. Corporate Tax Structure

    24.1.11. Investments

    24.1.12. Major Companies

    24.2. Middle East Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    24.3. Middle East Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    24.4. Middle East Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    24.5. Middle East Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

    24.6. Middle East Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

    24.7. Middle East Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

    24.8. Middle East Central Nervous System Drugs Market Metrics

    24.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Middle East Major Countries

    24.9. Middle East Central Nervous System Drugs Market: Country Analysis

    24.10. Israel Central Nervous System Drugs Market

    24.11. Israel Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    24.12. Israel Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    24.13. Saudi Arabia Central Nervous System Drugs Market

    24.14. Saudi Arabia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    24.15. Saudi Arabia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    24.16. Turkey Central Nervous System Drugs Market

    24.17. Turkey Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    24.18. Turkey Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    24.19. UAE Central Nervous System Drugs Market

    24.20. UAE Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    24.21. UAE Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    25. Africa Central Nervous System Drugs Market

    25.1. Africa Central Nervous System Drugs Market Overview

    25.1.1. Region Information

    25.1.2. Market Information

    25.1.3. COVID-19 Impact

    25.1.4. Background Information

    25.1.5. Government Initiatives

    25.1.6. Regulations

    25.1.7. Regulatory Bodies

    25.1.8. Major Associations

    25.1.9. Taxes Levied

    25.1.10. Corporate Tax Structure

    25.1.11. Investments

    25.1.12. Major Companies

    25.2. Africa Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    25.3. Africa Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    25.4. Africa Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    25.5. Africa Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

    25.6. Africa Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

    25.7. Africa Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

    25.8. Africa Central Nervous System Drugs Market Metrics

    25.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Africa Major Countries

    25.9. Africa Central Nervous System Drugs Market: Country Analysis

    25.10. Egypt Central Nervous System Drugs Market

    25.11. Egypt Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    25.12. Egypt Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    25.13. Nigeria Central Nervous System Drugs Market

    25.14. Nigeria Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    25.15. Nigeria Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    25.16. South Africa Central Nervous System Drugs Market

    25.17. South Africa Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    25.18. South Africa Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    26. Global Central Nervous System Drugs Market Competitive Landscape

    26.1. Biogen Inc.

    26.1.1. Company Overview

    26.1.2. Products And Services

    26.1.3. Business Strategy

    26.1.4. Financial Overview

    26.2. Johnson & Johnson

    26.2.1. Company Overview

    26.2.2. Products And Services

    26.2.3. Business Strategy

    26.2.4. Financial Overview

    26.3. Hoffmann-La Roche Ltd

    26.3.1. Company Overview

    26.3.2. Products And Services

    26.3.3. Business Strategy

    26.3.4. Financial Overview

    26.4. Novartis AG

    26.4.1. Company Overview

    26.4.2. Products And Services

    26.4.3. Business Strategy

    26.4.4. Financial Overview

    26.5. UCB

    26.5.1. Company Overview

    26.5.2. Products And Services

    26.5.3. Business Strategy

    26.5.4. Financial Overview

    27. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

    27.1. Ethypharm Acquired Altan Pharma

    27.2. Angelini Pharma Acquired Arvelle Therapeutics

    27.3. Novartis Acquired Cadent Therapeutics

    27.4. Biogen Acquired Sangamo Therapeutics

    27.5. Supernus Acquired US WorldMeds

    27.6. Permira Acquired Neuraxpharm

    27.7. UCB Acquired Handl Therapeutics

    27.8. Neurocrine Biosciences Acquired Voyager Therapeutics

    27.9. Eli Lilly Acquired Loxo Oncology Inc.

    27.10. Neuraxpharm Acquired Farmax

    27.11. CNS Pharmaceuticals Acquired Houston Pharmaceuticals Inc.

    27.12. H. Lundbeck Acquired Prexton Therapeutics

    27.13. Novartis Acquired AveXis

    27.14. Biolab Pharma Acquired Avtavis Brazil

    27.15. Mitsubishi Tanabe Pharma Acquired NeuroDerm

    27.16. Eli Lilly Acquires CoLucid

    27.17. Lupin Acquired Temmler Pharma

    28. Market Background: Pharmaceutical Drugs Market

    28.1. Pharmaceutical Drugs Market Characteristics

    28.1.1. Market Definition

    28.1.2. Segmentation By Type

    28.2. Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2025, Value ($ Billion)

    28.3. Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)

    28.4. Global Pharmaceutical Drugs Market, 2015 – 2025, Historic And Forecast, By Region

    29. Central Nervous System Drugs Market Future Outlook and Potential Analysis

    29.1. Global Central Nervous System Drugs Market In 2025 – Countries Offering Most New Opportunities

    29.2. Global Central Nervous System Drugs Market In 2025 – Segments Offering Most New Opportunities

    29.3. Global Central Nervous System Drugs Market In 2025 – Growth Strategies

    29.3.1. Market Trend Based Strategies

    29.3.2. Competitor Strategies

    30. Appendix

    30.1. Market Data Sources

    30.2. NAICS Definitions Of Industry Covered In This Report

    30.3. Research Methodology

    30.4. Currencies

    30.5. Research Inquiries

    30.6. The Business Research Company

    30.7. Copyright and Disclaimer

List Of Tables

    Table 1 : Global Central Nervous System Drugs Market, Product Analysis – Product Examples
  • Table 2: Global Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 3: Global Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 4: Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 5: Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 6: Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
  • Table 7: Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
  • Table 8: Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 9: Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 10: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 11: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 12: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 13: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 14: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 15: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 16: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 17: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 18: Global Central Nervous System Drugs Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2025
  • Table 19: Global Central Nervous System Drugs Market, Per Capita Average Central Nervous System Drugs Market Industry Expenditure, 2015 – 2025, ($)
  • Table 20:  Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 21:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 22: Asia-Pacific Per Capita Net Disposable Income, 2015-2019, $
  • Table 23:  Asia Pacific Population By Age Group, 2015-2023, Thousands
  • Table 24: Asia-Pacific Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 25: Asia-Pacific Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 26: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 27: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 28: Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Table 29: Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 30: Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 31: Asia-Pacific Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
  • Table 32: Australia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 33: Australia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 34: Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 35: Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 36:  China Pharmaceuticals, 2015-2020, $ Billion
  • Table 37:  China Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 38:  China Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 39: China Per Capita Net Disposable Income, 2015-2019, $
  • Table 40:  China Population By Age Group, 2015-2023, Thousands
  • Table 41: China Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 42: China Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 43: China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 44: China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 45: Hong Kong Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 46: Hong Kong Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 47: India Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 48: India Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 49: India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 50: India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 51: Indonesia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 52: Indonesia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 53: Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 54: Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 55: Japan Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 56: Japan Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 57: Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 58: Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 59: Malaysia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 60: Malaysia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 61: New Zealand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 62: New Zealand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 63: Philippines Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 64: Philippines Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 65: Singapore Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 66: Singapore Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 67: South Korea Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 68: South Korea Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 69: South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 70: South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 71: Thailand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 72: Thailand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 73: Vietnam Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 74: Vietnam Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 75: Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 76: Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 77: Western Europe Per Capita Net Disposable Income, 2015-2019, $
  • Table 78:  Western Europe Population By Age Group, 2015-2023, Thousands
  • Table 79: Western Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 80: Western Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 81: Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 82: Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 83: Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Table 84: Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 85: Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 86: Western Europe Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
  • Table 87: Austria Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 88: Austria Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 89: Belgium Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 90: Belgium Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 91: Denmark Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 92: Denmark Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 93: Finland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 94: Finland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 95: France Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 96: France Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 97: France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 98: France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 99: Germany Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 100: Germany Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 101: Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 102: Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 103: Ireland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 104: Ireland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 105: Italy Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 106: Italy Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 107: Netherlands Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 108: Netherlands Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 109: Norway Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 110: Norway Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 111: Portugal Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 112: Portugal Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 113: Spain Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 114: Spain Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 115: Sweden Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 116: Sweden Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 117: Switzerland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 118: Switzerland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 119: UK Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 120: UK Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 121: UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 122: UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 123: Eastern Europe Public Healthcare Expenditure, 2015-2019,$Billion
  • Table 124: Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 125: Eastern Europe Per Capita Net Disposable Income, 2015-2019, $
  • Table 126:  Eastern Europe Population By Age Group, 2015-2023, Thousands
  • Table 127: Eastern Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 128: Eastern Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 129: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 130: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 131: Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Table 132: Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 133: Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 134: Eastern Europe Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
  • Table 135: Czech Republic Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 136: Czech Republic Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 137: Poland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 138: Poland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 139: Romania Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 140: Romania Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 141: Russia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 142: Russia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 143: Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 144: Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 145:  North America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 146:  North America Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 147: North America Per Capita Net Disposable Income, 2015-2019, $
  • Table 148:  North America Population By Age Group, 2015-2023, Thousands
  • Table 149: North America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 150: North America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 151: North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 152: North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 153: North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Table 154: North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 155: North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 156: North America Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
  • Table 157: Canada Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 158: Canada Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 159: Mexico Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 160: Mexico Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 161:  USA Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 162:  USA Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 163: USA Per Capita Net Disposable Income, 2015-2019, $
  • Table 164:  USA Market, Population By Age Group, 2015-2023, Thousands
  • Table 165: USA Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 166: USA Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 167: USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 168: USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 169: South America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 170: South America Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 171: South America Per Capita Net Disposable Income, 2015-2019, $
  • Table 172:  South America Population By Age Group, 2015-2023, Thousands
  • Table 173: South America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 174: South America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 175: South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 176: South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 177: South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Table 178: South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 179: South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 180: South America Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $

List Of Figures

    Figure 1: Global Central Nervous System Drugs Market Segmentation By Type
  • Figure 2: Global Central Nervous System Drugs Market Segmentation By Distribution Channel
  • Figure 3: Global Central Nervous System Drugs Market Segmentation By Route Of Administration
  • Figure 4: Global Central Nervous System Drugs Market Segmentation By Drug Classification
  • Figure 5: Global Central Nervous System Drugs Market Segmentation By Mode Of Purchase
  • Figure 6: Market Supply Chain For Central Nervous System Drugs
  • Figure 7: Global Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 8: Global Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 9: Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 10: Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
  • Figure 11: Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
  • Figure 12: Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 13: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 14: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 15: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 16: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 17: Asia-Pacific Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 18: Asia-Pacific Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 19: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 20: Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 21: Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 22: Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 23: Australia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 24: Australia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 25: Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 26: China Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 27: China Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 28: China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 29: Hong Kong Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 30: Hong Kong Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 31: India Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 32: India Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 33: India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 34: Indonesia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 35: Indonesia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 36: Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 37: Japan Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 38: Japan Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 39: Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 40: Malaysia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 41: Malaysia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 42: New Zealand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 43: New Zealand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 44: Philippines Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 45: Philippines Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 46: Singapore Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 47: Singapore Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 48: South Korea Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 49: South Korea Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 50: South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 51: Thailand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 52: Thailand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 53: Vietnam Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 54: Vietnam Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 55: Western Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 56: Western Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 57: Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 58: Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 59: Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 60: Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 61: Austria Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 62: Austria Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 63: Belgium Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 64: Belgium Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 65: Denmark Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 66: Denmark Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 67: Finland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 68: Finland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 69: France Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 70: France Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 71: France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 72: Germany Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 73: Germany Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 74: Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 75: Ireland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 76: Ireland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 77: Italy Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 78: Italy Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 79: Netherlands Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 80: Netherlands Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 81: Norway Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 82: Norway Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 83: Portugal Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 84: Portugal Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 85: Spain Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 86: Spain Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 87: Sweden Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 88: Sweden Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 89: Switzerland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 90: Switzerland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 91: UK Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 92: UK Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 93: UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 94: Eastern Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 95: Eastern Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 96: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 97: Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 98: Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 99: Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 100: Czech Republic Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 101: Czech Republic Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 102: Poland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 103: Poland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 104: Romania Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 105: Romania Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 106: Russia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 107: Russia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 108: Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 109: North America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 110: North America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 111: North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 112: North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 113: North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 114: North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 115: Canada Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 116: Canada Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 117: Mexico Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 118: Mexico Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 119: USA Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 120: USA Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 121: USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 122: South America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 123: South America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 124: South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 125: South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 126: South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 127: South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 128: Argentina Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 129: Argentina Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 130: Brazil Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 131: Brazil Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 132: Brazil Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 133: Chile Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 134: Chile Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 135: Colombia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 136: Colombia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 137: Peru Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 138: Peru Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 139: Venezuela Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 140: Venezuela Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 141: Middle East Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Analgesics Global Market Report 2024 – By Type (Non-opioids, Opioids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores), By Application (Internal Analgesics, External Analgesics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Antiemetics And Antinauseants Global Market Report 2024 – By Drug (Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types), By Application (Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types), By End Users (Hospital, Medical Center, Clinic, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Anti-Parkinson Drugs Global Market Report 2024 – By Drugs Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs ), By Route of Administration (Oral, Injection, Transdermal ), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Anesthetics Global Market Report 2024 – By Type (General Anesthetics, Local Anesthetics), By Route of Administration (Inhalation Anesthesia Drugs, Intravenous Anesthesia Drugs, Topical Anesthesia Drugs), By Application (General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Generic Pharmaceuticals Global Market Report 2024 – By Type (Biosimilars, Generics), By Drug Delivery (Oral, Injectables, Dermal/Topical, Inhaled), By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Brain And Neuroimaging Devices Global Market Report 2024 – By Imaging Type (Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG), Other Imaging Types), By Application (Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders, Other Applications), By End-user (Hospitals, Diagnostic Centres, Ambulatory Surgical Centres) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Antibody Drug Conjugates Global Market Report 2024 – By Type (Monoclonal Antibodies, Linker, Drug/Toxin, Other Types), By Product (Adcertis, Kadcyla, Other Products), By Technology (Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Other Technology), By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Other Applications), By End User (Hospital, Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Brain Tumor Drugs Market 2022 - By Drugs (Temozolomide, Bevacizumab), By End User (Hospital Pharmacies, Retail Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Frequently Asked Questions

What is the definition of the central nervous system drugs market?

The central nervous system (CNS) drugs market consists of sales of central nervous system drugs and related services by entities that manufacture central nervous system drugs that are used in the treatment of diseases affecting the brain or spinal cord request a sample here

How will the central nervous system drugs market drivers and restraints affect central nervous system drugs market dynamics? What forces will shape the central nervous system drugs industry going forward?

The central nervous system (CNS) drugs market growth is aided by rapid growth in emerging markets. However, some central nervous system (CNS) drugs market restraints include patent expiration of branded central nervous system drugs. request a sample here

What is the forecast market size of the central nervous system drugs market?

The central nervous system (CNS) drugs market forecast is expected to reach $163.05 billion in 2025 at a compound annual growth rate of 6%. request a sample here

How is the central nervous system drugs market segmented?

The global central nervous system drugs market is segmented -
1) By Type: Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs request a sample here

Which region has largest share, and what is the market size and growth by geography according to the central nervous system drugs global market report?

For more detail on this, request a sample here.

Who are the key players of the global central nervous system drugs market?

Top competitors in the central nervous system (CNS) drugs market are Biogen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc, Novartis AG. request a sample here.

What are the key trends in the global central nervous system drugs market?

Major trends influencing the central nervous system (CNS) drugs market include collaboration with other manufacturers in the industry to share technical knowledge and improve product quality request a sample here.

What are the major opportunities in the central nervous system drugs market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global central nervous system drugs market, request a sample here.

How does the central nervous system drugs market relate to the overall economy and other similar markets?

request a sample here.

request a sample here.

request a sample here.